The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 10 2021
Historique:
received: 06 02 2021
accepted: 21 09 2021
entrez: 9 10 2021
pubmed: 10 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

Despite the involvement of Poly(ADP-ribose) polymerase-1 (PARP1) in many important biological pathways, the target residues of PARP1-mediated ADP-ribosylation remain ambiguous. To explicate the ADP-ribosylation regulome, we analyze human cells depleted for key regulators of PARP1 activity, histone PARylation factor 1 (HPF1) and ADP-ribosylhydrolase 3 (ARH3). Using quantitative proteomics, we characterize 1,596 ADP-ribosylation sites, displaying up to 1000-fold regulation across the investigated knockout cells. We find that HPF1 and ARH3 inversely and homogenously regulate the serine ADP-ribosylome on a proteome-wide scale with consistent adherence to lysine-serine-motifs, suggesting that targeting is independent of HPF1 and ARH3. Notably, we do not detect an HPF1-dependent target residue switch from serine to glutamate/aspartate under the investigated conditions. Our data support the notion that serine ADP-ribosylation mainly exists as mono-ADP-ribosylation in cells, and reveal a remarkable degree of histone co-modification with serine ADP-ribosylation and other post-translational modifications.

Identifiants

pubmed: 34625544
doi: 10.1038/s41467-021-26172-4
pii: 10.1038/s41467-021-26172-4
pmc: PMC8501107
doi:

Substances chimiques

Carrier Proteins 0
HPF1 protein, human 0
Histones 0
Nuclear Proteins 0
Proteome 0
Serine 452VLY9402
Adenosine Diphosphate 61D2G4IYVH
Glycoside Hydrolases EC 3.2.1.-
ADPRS protein, human EC 3.2.1.143

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5893

Subventions

Organisme : Wellcome Trust
ID : 101794
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210634
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007195/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C35050/A22284
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Rapid Commun Mass Spectrom. 1993 Aug;7(8):738-43
pubmed: 8374164
Biochem Biophys Res Commun. 1963 Apr 2;11:39-43
pubmed: 14019961
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nat Commun. 2018 Aug 13;9(1):3233
pubmed: 30104678
Cell Rep. 2017 Nov 21;21(8):2326-2337
pubmed: 29166620
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Sci Rep. 2017 Mar 02;7:43750
pubmed: 28252050
Cell Rep. 2018 Aug 28;24(9):2493-2505.e4
pubmed: 30157440
Biochemistry. 1979 Mar 20;18(6):983-90
pubmed: 106878
Elife. 2018 Feb 26;7:
pubmed: 29480802
Bioinformatics. 2005 Apr 1;21(7):951-60
pubmed: 15531603
Nature. 2012 Jan 18;481(7381):287-94
pubmed: 22258607
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2783-8
pubmed: 21270334
Nat Struct Mol Biol. 2020 Apr;27(4):310-312
pubmed: 32231290
Nat Rev Mol Cell Biol. 2006 Jul;7(7):517-28
pubmed: 16829982
Nature. 2016 Jul 20;535(7612):382-7
pubmed: 27443740
Nat Commun. 2021 Jul 1;12(1):4055
pubmed: 34210965
J Proteome Res. 2014 Aug 1;13(8):3510-22
pubmed: 24920161
Cell. 2020 Nov 12;183(4):1086-1102.e23
pubmed: 33186521
Mol Cell Proteomics. 2019 May;18(5):1010-1026
pubmed: 30798302
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Nat Struct Mol Biol. 2013 Apr;20(4):502-7
pubmed: 23474714
Cell Rep. 2020 Sep 22;32(12):108176
pubmed: 32966781
Anal Chem. 2017 Feb 7;89(3):1523-1530
pubmed: 28035797
Mol Cell. 2021 Jun 17;81(12):2640-2655.e8
pubmed: 34019811
Genes Dev. 2012 Mar 1;26(5):417-32
pubmed: 22391446
J Am Chem Soc. 2009 Oct 14;131(40):14258-60
pubmed: 19764761
EMBO J. 2005 Jun 1;24(11):1911-20
pubmed: 15902274
Oncogene. 1999 Aug 12;18(32):4616-25
pubmed: 10467406
FEBS J. 2017 Dec;284(23):4002-4016
pubmed: 29054115
Nat Chem Biol. 2016 Dec;12(12):998-1000
pubmed: 27723750
FEBS J. 2021 Apr;288(7):2131-2142
pubmed: 32785980
Nature. 2020 Sep;585(7826):609-613
pubmed: 32939087
Genes Dev. 2011 Mar 1;25(5):409-33
pubmed: 21363960
Nat Commun. 2016 Sep 30;7:12917
pubmed: 27686526
Biochemistry. 2004 Jan 13;43(1):210-6
pubmed: 14705947
Mol Cell. 2013 Oct 24;52(2):272-85
pubmed: 24055347
J Proteome Res. 2011 Apr 1;10(4):1785-93
pubmed: 21309581
Biochemistry. 1984 Jul 31;23(16):3726-30
pubmed: 6477891
Trends Cell Biol. 2011 Sep;21(9):534-42
pubmed: 21741840
Nat Commun. 2020 Jul 7;11(1):3391
pubmed: 32636369
FEBS Lett. 1983 Aug 22;160(1-2):217-20
pubmed: 6309564
Methods Enzymol. 2019;626:301-321
pubmed: 31606080
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9463-8
pubmed: 15983376
Nat Commun. 2017 Dec 12;8(1):2055
pubmed: 29234005
J Am Soc Mass Spectrom. 2015 Nov;26(11):1848-57
pubmed: 26111518
Nat Med. 2013 Nov;19(11):1381-8
pubmed: 24202391
Biochemistry. 1970 Oct 27;9(22):4396-401
pubmed: 5472711
EMBO J. 2013 May 2;32(9):1225-37
pubmed: 23481255
Mol Cell Proteomics. 2020 Dec 11;20:100018
pubmed: 33568339
Crit Rev Biochem Mol Biol. 2018 Feb;53(1):64-82
pubmed: 29098880
Mol Biosyst. 2017 Nov 21;13(12):2660-2671
pubmed: 29058739
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621
pubmed: 28676700
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
J Biol Chem. 1979 Apr 25;254(8):3029-37
pubmed: 218926
EMBO J. 2003 May 1;22(9):2255-63
pubmed: 12727891
EMBO J. 1988 Jan;7(1):57-67
pubmed: 3359995
Nature. 2020 Mar;579(7800):598-602
pubmed: 32028527
Nat Methods. 2013 Oct;10(10):981-4
pubmed: 23955771
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7136-41
pubmed: 16627622
J Biol Chem. 1980 Aug 25;255(16):7616-20
pubmed: 6772638
Mol Cell. 2017 Mar 2;65(5):932-940.e6
pubmed: 28190768
J Biol Chem. 2002 Jun 21;277(25):23028-36
pubmed: 11948190
Annu Rev Biochem. 2016 Jun 2;85:431-54
pubmed: 26844395
Nat Commun. 2020 Oct 15;11(1):5199
pubmed: 33060572
Biochemistry. 1984 Jul 31;23(16):3721-5
pubmed: 6089879
Curr Top Microbiol Immunol. 2015;384:33-50
pubmed: 25113886
Elife. 2017 Jun 26;6:
pubmed: 28650317
Open Biol. 2020 Nov;10(11):200237
pubmed: 33202171
Nature. 2011 Sep 04;477(7366):616-20
pubmed: 21892188
Epigenetics Chromatin. 2013 Jan 05;6(1):1
pubmed: 23289424
Elife. 2021 Mar 08;10:
pubmed: 33683197
Nat Methods. 2009 Nov;6(11):786-7
pubmed: 19876014
Curr Biol. 2017 Dec 4;27(23):R1256-R1258
pubmed: 29207261
Mol Cell. 2016 May 5;62(3):432-442
pubmed: 27067600
Angew Chem Int Ed Engl. 2012 Feb 6;51(6):1383-6
pubmed: 22213128
Cell Rep. 2018 Sep 25;24(13):3488-3502.e5
pubmed: 30257210
Mol Cell. 2015 Jun 18;58(6):902-10
pubmed: 26091339
J Biol Chem. 1985 Dec 25;260(30):16187-91
pubmed: 3934172

Auteurs

Ivo A Hendriks (IA)

Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.

Sara C Buch-Larsen (SC)

Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.

Evgeniia Prokhorova (E)

Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.

Jonas D Elsborg (JD)

Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.

Alexandra K L F S Rebak (AKLFS)

Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.

Kang Zhu (K)

Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.

Dragana Ahel (D)

Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.

Claudia Lukas (C)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.

Ivan Ahel (I)

Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.

Michael L Nielsen (ML)

Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark. michael.lund.nielsen@cpr.ku.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH